Side-by-side financials for CLGN and ALGN. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CLGN | ALGN |
|---|---|---|
| Market cap | - | $12.21 B |
| US-listed rank | - | #828 |
| Revenue (latest FY) | $2.37M | $4.03B |
| Net income (latest FY) | -$11.49M | $410.00M |
| Net margin | -484.6% | 10.2% |
| P/E (trailing FY) | - | 29.8 |
| SEC filings | 317 | 2,096 |
In their latest fiscal years, CollPlant Biotechnologies Ltd reported $2.37M in revenue while ALIGN TECHNOLOGY INC reported $4.03B.
Full pages: CollPlant Biotechnologies Ltd and ALIGN TECHNOLOGY INC, or browse the full rankings.